Company

Freedom Meditech is focused on the development and commercialization of medical device technologies that provide users worldwide with a more “free and healthy” alternative to existing diagnostic tools on the market.  The company was incorporated in December 2006, with activities to-date including; due diligence on numerous early-stage medical device technologies, related research, intellectual property (IP) evaluation, management/advisor recruiting, product development planning, licensing negotiations, and business development activities.  Freedom Meditech has been founded with the intent of licensing, developing, and commercializing medical device technologies with clear market need and overall global appeal.

Freedom Meditech’s current core proprietary technology is a novel eye-related diabetes medical device that is being developed so to provide diabetic persons with a more convenient and pain-free alternative to the “finger prick” method of glucose measurement and monitoring.  Our patented technology platform 1) is non-invasive, 2) entails shining a light in a person’s eye to obtain glucose information, and 3) is being designed to display glucose information in digital format on the handheld device (the size of small binoculars) taking the reading.

Freedom Meditech’s proposed glucose measurement device has clear end-user appeal and the potential to create a paradigm shift in the ~$8 billion global diabetes medical device market.   Currently, there is no non-invasive blood glucose measuring device approved by the FDA or actively sold.

Freedom Meditech is currently raising capital for pilot human studies.

To date, our patented prototype has been validated via in-vitro and modified animal studies, with accurate and repeatable data obtained and published in the highly regarded and peer reviewed "Diabetes Technology and Therapeutics" magazine.  Continued product development activities, clinical studies, and all other corporate matters are being led from San Diego, California.